Clinical trial
A Prospective, Multicenter, Single Arm Clinical Trial to Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms
NCT06158750 is registered in ClinicalTrials.gov with Shanghai Wallaby Medical Technologies Co.,Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Single Arm Clinical Trial to Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms
- Lead sponsor
- Shanghai Wallaby Medical Technologies Co.,Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 17, 2023
- Completion date
- June 30, 2026
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.